Search Results 71-80 of 18472 for total bilirubin

1. A Research Study to Evaluate Safety and Efficacy of DUR-928 in Subjects With Primary Sclerosing Cholangitis (PSC) - Mayo Clinic

   Total Bilirubin > 2.5 mg/dL. International normalized ratio (INR) ≥ 1.2. Subjects on anticoagulant therapy. Platelet count < 150,000/mm3. Immunoglobulin G4 ...

2. Imiquimod and Pembrolizumab in Treating Patients With Stage IIIB-IV Melanoma - Mayo Clinic

   Serum total bilirubin ≤ 1.5 X upper limit of normal (ULN) or direct bilirubin ≤ (ULN) for subjects with total bilirubin levels > 1.5 ULN;; Aspartate ...

3. Phase 2 Study of Ruxolitinib Versus Anagrelide in Subjects With Essential Thrombocythemia Who Are Resistant to or Intolerant of Hydroxyurea (RESET-272) - Mayo Clinic

   Total bilirubin > 1.5 × upper limit of normal (ULN); Aspartate aminotransferase or alanine aminotransferase > 1.5 × ULN; Hepatocellular disease (eg, cirrhosis).

4. Nivolumab in Treating Patients With Recurrent and/or Metastatic Nasopharyngeal Cancer - Mayo Clinic

   Serum total bilirubin < 2 x ULN (except patients with Gilbert syndrome, who can have total bilirubin < 3.0 mg/dL); Serum creatinine < 1.5 x ULN. Exclusion ...

5. Taselisib and Enzalutamide in Treating Patients With Androgen Receptor Positive Triple-Negative Metastatic Breast Cancer - Mayo Clinic

   Total serum bilirubin =< 1.5 x ULN (in patients with known Gilbert syndrome, a total bilirubin =< 3.0 x ULN, with direct bilirubin =< 1.5 x ULN); Aspartate ...

6. A Study to Evaluate the Effectiveness of Spesolimab to Treat Hidradenitis Suppurativa - Mayo Clinic

   ... total bilirubin. Patients with Gilbert´s syndrome can be included unless total bilirubin elevation is > 5-fold ULN at screening visit and unless proportions ...

7. A Study to Evaluate AMG 701 in Subjects with Multiple Myeloma - Mayo Clinic

   a serum M protein ≥ 0.5 g/dL measured by serum protein ... In patients with Gilberts syndrome, enrollment will be allowed if the level of total bilirubin ...

8. Study Using Chromogranin A As Surveillance Biomarker In Patients With CARcinoids - Mayo Clinic

   Severe liver dysfunction in the absence of liver metastasis defined by aspartate aminotransferase (AST), serum total bilirubin and/or alanine transaminase ...

9. Nivolumab With or Without Ipilimumab in Treating Patients With Refractory Metastatic Anal Canal Cancer - Mayo Clinic

   - Total bilirubin ≤ 1.5 x institutional upper limit of normal (ULN) (except patients ... [SGOT])/alanine aminotransferase (ALT) (serum glutamate pyruvate ...

10. Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25 - Mayo Clinic

    - Total bilirubin greater than ULN (upper limit of normal) for the lab or greater than 1.5 x ULN for patients who have a bilirubin elevation due to ...